Skip to main content
Journal of Neurosurgery: Case Lessons logoLink to Journal of Neurosurgery: Case Lessons
. 2026 Nov 9;12(19):CASE26535. doi: 10.3171/CASE26535

Paired vagus nerve stimulation therapy for posterior circulation ischemic strokes: illustrative cases

Taylor G Burch 1, Anthony K Nwankwo 1, Micaela C Nelson 2, Andrea C Zoana 3, Shashank N Patil 1, Sarah Rose Horowitz 2, Genaro Herrera Cano 2, Ravi H Gandhi 3,4, Chandan G Reddy 3,4, Christopher R Conner 1,✉
PMCID: PMC13755643  PMID: 43002758

Abstract

BACKGROUND

While the global disability burden due to stroke remains substantial, the emergence of novel neurorestorative therapies offers new opportunities for poststroke recovery. Vagus nerve stimulation (VNS) paired with upper extremity (UE) rehabilitation (paired VNS) is an FDA-approved therapy shown to improve UE impairment and reduce motor deficits in patients with chronic stroke. However, published evidence describing its use in posterior circulation strokes is limited.

OBSERVATIONS

This case series presents 4 patients with persistent UE impairment following posterior fossa strokes who underwent implantation and treatment with paired VNS months to years after their cerebrovascular event. Functional improvements were observed in all cases, including gains in Fugl-Meyer Assessment for Upper Extremity or Wolf Motor Function Test scores. All patients also reported improved functional use of the affected limb during daily activities and improvements in their quality of life.

LESSONS

These cases suggest that paired VNS therapy may support meaningful functional recovery following posterior fossa stroke, even years after the initial event. Improvements were observed in both objective motor outcomes and patient-reported function and quality of life. These observations expand the clinical experience with paired VNS in a stroke subpopulation associated with significant long-term disability, and contribute to addressing a gap in the literature.

https://thejns.org/doi/10.3171/CASE26535

Keywords: electric stimulation therapy, infarction, posterior cerebral artery, ischemic stroke, stroke rehabilitation, vagus nerve stimulation

ABBREVIATIONS: ADL = activities of daily living, FMA-UE = Fugl-Meyer Assessment for Upper Extremity, MCID = minimal clinically important difference, UE = upper extremity, VNS = vagus nerve stimulation, WMFT = Wolf Motor Function Test, NIHSS = National Institutes of Health Stroke Scale


Globally, stroke is the third leading cause of disability-adjusted life years and is projected to increase further.1,2 Nearly 50%–60% of patients who have had a stroke are impacted by chronic upper extremity (UE) motor deficits contributing to significant disability.3,4 Although posterior fossa strokes only account for 20%–25% of all ischemic strokes, this population is particularly vulnerable because strokes in this location are associated with worse outcomes and are often misdiagnosed due to diverse clinical presentations.5,6This work builds on the landmark findings of the VNS-REHAB trial7 and was further validated through successful institutional implementation.8 Vagus nerve stimulation (VNS) paired with rehabilitation therapy (paired VNS) has emerged as an effective, FDA-approved treatment for chronic UE motor deficits after ischemic stroke. This treatment modality involves stimulating the vagus nerve to increase afferent input to regions like the basal forebrain, raphe nuclei, and locus coeruleus,9 resulting in the release of neuromodulators within the cortex that promote plasticity.10 To date, preclinical and clinical studies have predominantly focused on supratentorial infarcts or omitted stroke location altogether; thus, the use of paired VNS for posterior fossa ischemic stroke recovery is underreported in the literature.11 In this series, we report the first 4 patients with posterior fossa strokes to undergo paired VNS therapy with Vivistim paired VNS (personal communication between C.R.C. and the manufacturer) for persistent UE motor deficits.

Each patient presented months to years poststroke with chronic, moderate to severe UE disability, defined by a score of 20–55 on the Fugl-Meyer Assessment for Upper Extremity (FMA-UE)12,13 or < 4 of 5 on the Wolf Motor Function Test (WMFT).13 After undergoing paired VNS, all 4 patients demonstrated improvement in UE function per objective WMFT or FMA-UE performance and subjective reports.

Illustrative Cases

Therapeutic Intervention of Cases

Each patient was screened and met the Vivistim FDA on-label indication of being adults with a history of moderate to severe chronic UE deficits after ischemic stroke. The major contraindication to implantation is a history of vagotomy. VNS device implantation was performed in a standard fashion for each patient. The left vagus nerve was reached via an anterior trans-platysmal posterolateral approach to the carotid sheath. Once identified, the nerve was wrapped with stimulator leads. The lead wire was secured with anchors, tunneled caudally, and connected to an implanted pulse generator in a subcutaneous pocket in the anterior chest. Hemostasis and device functionality were confirmed. All patients were discharged home the same day without any complications.

Following implantation, patients completed 6 weeks of structured in-clinic paired VNS, focused on proximal mobility, fine motor coordination, and functional independence of the affected UE. Additional therapeutic personalization addressed patient-specific goals. Patients were also encouraged to self-activate the device out-of-clinic up to 8 times daily for standard 30-minute sessions, during activities of daily living (ADL) in need of improvement.

Case 1

Clinical Presentation

Patient 1 is a 67-year-old right-handed male with a history of hypertension, hyperlipidemia, and prediabetes who sustained a right anterior medullary stroke (Fig. 1) secondary to small-vessel disease, with an initial National Institutes of Health Stroke Scale (NIHSS) score of 2 (left upper and lower extremity drift).

FIG. 1.

FIG. 1.

Case 1. Axial diffusion-weighted (left) and apparent diffusion coefficient (right) MRI sequences demonstrating restricted diffusion at the ventral aspect of the right anterior medullary pyramid consistent with an acute ischemic infarct (arrow).

Brain MRI confirmed an acute right anterior medullary ischemic stroke with evidence of chronic left corona radiata and right thalamic infarcts. He did not receive thrombolysis or thrombectomy.

On discharge, the assigned NIHSS score was 4 (left arm drift, left leg drift, and mild to moderate sensory loss on the affected side) and the modified Rankin Scale score was 4.

Six months poststroke, after experiencing a plateau of his functional recovery despite inpatient and outpatient rehabilitation, he was referred for consideration of paired VNS. Physical examination was notable for a mild left distal hemiparesis (4/5 strength in wrist extension, wrist flexion, hand intrinsics, ankle dorsiflexion and plantar flexion) and nondebilitating left UE spasticity (grade 2 on the Modified Ashworth Scale).

Pretreatment evaluation revealed a WMFT score of 3.7 of 5, consistent with moderate impairment. He elected to undergo paired VNS with the goals of returning to farmwork and golfing.

Follow-Up and Outcomes

After completion of the 6-week paired VNS therapy program, his posttreatment WMFT score increased substantially by 1.1 points (minimal clinically important difference [MCID] 0.4)13,14 to a score of 4.8 of 5, which allowed him to complete simple tasks in less time. His 3-month postoperative visit was notable for marked improvement in his UE function, permitting full return to farmwork and golf, and his distal left UE strength had improved to 4+/5 on examination.

Case 2

Clinical Presentation

Patient 2 is a 78-year-old right-handed female with a history of hypertension, hyperlipidemia, prediabetes, a cardiac pacemaker, and former smoking who experienced an ischemic stroke of the left-sided mid-pons (Fig. 2) secondary to a thromboembolic event. The initial NIHSS score was 3 (mild facial weakness, right UE drift, and decreased sensation on the affected side), and MRI confirmed an acute left pontine stroke, with evidence of additional chronic subcapsular and bilateral striatocapsular infarcts. She did not receive ­thrombolysis or thrombectomy. Despite several weeks of inpatient and outpatient rehabilitation, she regained limited ambulatory capacity and required high assistance with ADL, primarily due to persistent right UE deficits.

FIG. 2.

FIG. 2.

Case 2. Axial diffusion-weighted MRI sequence demonstrating restricted diffusion at the medial aspect of the left pons consistent with an acute ischemic infarct (arrow).

Four years poststroke, amid persistent motor deficits, the patient underwent evaluation for paired VNS to improve UE function for greater independence in ADL. Her preoperative FMA-UE score was 43 of 66, consistent with moderate to severe impairment. Neurological examination was notable for right-sided weakness (3/5 strength in right upper and lower extremities).

Follow-Up and Outcomes

After 6 weeks of paired VNS, her FMA-UE score had improved to 51 of 66, an 8-point gain from baseline.

By 6 months, her FMA-UE score had declined slightly to 47 of 66; however, she demonstrated a sustained improvement in proximal control.

She returned approximately 1 year later with a further decline in FMA-UE score to 43 of 66 (returning to her pre–paired VNS baseline). She nevertheless reported sustained improved UE motor control compared to preimplant status. Overall, she experienced a variable and ultimately modest benefit from paired VNS therapy.

Case 3

Clinical Presentation

Patient 3 is a 51-year-old right-handed male with a history of hypertension, diabetes, chronic kidney disease, atrial fibrillation, suspected autoimmune disorder, and multiple prior concussions who was diagnosed with an ischemic left ventral pontine brainstem stroke (Fig. 3) complicated by subsequent hemorrhagic transformation.

FIG. 3.

FIG. 3.

Case 3. Axial T2-weighted MRI sequence demonstrating a hypointense signal at the ventral aspect of the left pons consistent with an ischemic infarct (arrow).

The initial NIHSS score was not available; however, initial motor examination revealed severe right hemiparesis (1/5 in the proximal right upper and lower extremities and 0/5 distally). MRI revealed an acute ventral left paramedian pontine infarct. After standard inpatient and outpatient rehabilitation, he regained some ambulatory function with the use of a stimulation-assisted brace on his right lower extremity; however, severe right UE impairment and significant ADL difficulties persisted.

Eight years poststroke, the patient sought evaluation for paired VNS therapy. His initial FMA-UE score was 45 of 66, indicating moderate to severe motor impairment. His examination was notable for 3/5 strength throughout the right UE except for 1/5 strength in hand grip. His right lower extremity strength was 4/5 throughout. He had nonlimiting spasticity, with a Modified Ashworth Scale grade of 1+ in the right shoulder and biceps and 2 in the right wrist flexors.

Follow-Up and Outcomes

After 6 weeks of paired VNS, the patient’s FMA-UE score had improved to 55 of 66, reflecting a 10-point gain from baseline. In the ensuing 18 months, several challenges emerged necessitating long-term VNS device deactivation. This included the patient experiencing a myocardial infarction requiring placement of a defibrillator pacemaker and sequelae related to his autoimmune condition. Despite these limitations, the patient demonstrated sustained satisfaction and functional recovery, with 5/5 motor strength in the right upper and lower extremities on follow-up neurological examination.

Case 4

Clinical Presentation

Patient 4 is a 72-year-old right-handed female with a history of hypertension, hyperlipidemia, obesity, endometrial cancer, and type 2 diabetes with end organ complications who experienced a left-sided pontine lacunar infarct. Stroke imaging was unable to be obtained for this patient given that her scans were acquired at an outside institution.

The initial NIHSS score was 4 (minor right facial paresis, right arm drift, mild to moderate aphasia, and mild dysarthria). MRI confirmed a small acute infarct involving the left paramedian pons, without mass effect. CTA showed severe focal stenosis of the left P1 segment. She was deemed to not be a candidate for thrombolysis or thrombectomy. She underwent inpatient rehabilitation followed by outpatient rehabilitation but reported persistent right UE weakness, spasticity, and functional disability.

Three years poststroke, she underwent evaluation for paired VNS therapy for persistent UE motor deficits. Her preoperative FMA-UE score was 34 of 66, consistent with moderate to severe impairment. Her neurological examination was notable for right hemiparesis (3/5 strength in the right UE and 4/5 strength in the right lower extremity muscle groups). Spasticity was present but nonlimiting, with a Modified Ashworth Scale grade of 1+ in the right UE.

Follow-Up and Outcomes

Three days postoperatively, the patient developed a urinary tract infection treated empirically with a broad-spectrum antibiotic with resolution.

After 6 weeks of paired VNS, her FMA-UE score improved from 34 to 38 of 66 points. Overall, she demonstrated functional gains consistent with her personalized rehabilitation goals.

Informed Consent

This is a minimal risk retrospective chart review in which patient informed consent was not obtained at the time of treatment. The research involves no more than minimal risk and will not adversely affect the rights and welfare of the subjects. Harm was further minimized with appropriate data handling and standard encryption. Records were de-identified and secured through encrypted storage with access restricted to study personnel. There was no potential for physical risk to the patients.

Discussion

Paired VNS therapy has solidified its position in the medical armamentarium available to clinicians to treat patients who have experienced life-altering motor impairments due to ischemic stroke.

Although the results for paired VNS therapy are promising, the current literature fails to adequately report use of this treatment regimen in patients with posterior fossa infarctions. Preclinical studies aimed at investigating the use of implanted VNS for postischemic stroke rehabilitation primarily utilize murine cerebral stroke models involving transient or permanent occlusion of the middle cerebral artery, or targeted lesions of the motor cortex.14 Moreover, of the 9 currently published clinical studies, only the VNS-REHAB trial further stratified their population based on stroke location.15 Their subgroup analysis was stratified based on the presence of cortical versus subcortical involvement. Although the authors noted no significant difference in treatment regimen efficacy, it is unknown whether further delineation of the patient population based primarily on posterior circulation involvement could influence these results.

In this series, we present the first 4 patients who underwent paired VNS therapy with Vivistim for persistent UE motor deficits after ischemic stroke involving the posterior fossa structures. All 4 patients scored within the moderate to severe impairment range and had notable improvement after paired VNS, of whom 1 patient experienced regression back to baseline (Table 1).

TABLE 1.

Patient characteristics and their motor function scores

Case No. Age (yrs)/Sex Time Since Stroke Preop Score Postop Score Net Gain NIHSS Score on Admission
1 67/M 9 mos WMFT 3.7/5 WMFT 4.8/5 WMFT +1.1 4
2 78/F 4 yrs FMA-UE 43/66 FMA-UE
51/66 at 2 mos, 47/66 at 6 mos, 43/66 at 1 yr
FMA-UE +8 3
3 51/M 8 yrs FMA-UE 45/66 FMA-UE
55/66
FMA-UE +10 NA
4 72/F 3 yrs FMA-UE 34/66 FMA-UE
38/66
FMA-UE +4 4

NA = not available.

Observations

All 4 patients reported subjective notable increases in functional outcomes with paired VNS, compared to traditional rehabilitation alone. Of the 4 patients, 3 demonstrated an objective functional improvement above the MCID7,13,14 of 6 points for FMA-UE score or 0.4 points for WMFT score. Patient 1 made significant gains in functional improvement with a 1.1-point increase on the WMFT, almost triple the cited 0.4 MCID.13,14 Patient 2 also had a significant increase in functional gains with an 8-point increase in FMA-UE score after paired VNS, above the cited 6-point FMA-UE MCID.7 Unfortunately, this patient experienced a gradual regression back to baseline the following year. In contrast, patient 3 had a remarkable 10-point gain in FMA-UE score above the 6-point MCID and was able to maintain his functional outcomes, despite an extended time with VNS device deactivation in addition to noncontributory health issues. Finally, patient 4 demonstrated and maintained a 4-point increase in FMA-UE score. Although her increase in FMA-UE score was just below the MCID of 6,7 she reported personal satisfaction with her results from paired VNS. Overall, all 4 patients reported personal happiness with paired VNS and demonstrated objective gains in functional outcomes.

Although the VNS-REHAB study delineates cortical versus subcortical stokes, there remains a major gap discussing paired VNS for posterior fossa stroke.7

Lessons

To our knowledge, this series represents the first published description of paired VNS therapy in patients with posterior fossa ischemic stroke. All patients had persistent UE deficits despite prior conventional rehabilitation and subsequently demonstrated functional improvement following initiation of paired VNS therapy. In addition to objective motor gains, each patient reported increased functional use of the affected arm during ADL, as well as improvements in quality of life reflected by greater independence, social participation, and reengagement in hobbies and meaningful activities. While long-term functional recovery after stroke is highly variable, with traditional rehabilitation motor strength is thought to peak at 4 months.16 Given that our patients were referred between 6 months and 8 years poststroke, it is assumed that they had already reached their maximum recovery from rehabilitation alone prior to initiation of paired VNS therapy. This assumption can be further supported by the study design and findings of the pivotal triple-blind randomized VNS-REHAB clinical trial. The study addressed the potential misattribution of a functional improvement to VNS device activation rather than traditional rehabilitation by deactivating the device for control group patients and blinding patients, their treating therapists, and outcome assessors.7 VNS-REHAB found that although patients in the chronic phase of stroke recovery can improve with traditional rehabilitation alone, those utilizing paired VNS showed two to three times statistically significant improvement, comparatively.7

Several limitations should be acknowledged. This retrospective set of illustrative cases included only 4 patients and contained incomplete longitudinal data for some participants. Additionally, there are currently no preclinical or clinical studies specifically evaluating paired VNS therapy in posterior fossa stroke populations, limiting opportunities for direct comparison with existing literature.7,17–24 Ongoing real-world registry data may provide additional opportunities to evaluate heterogeneous stroke subpopulations and generate further insight into patient selection and functional outcomes following paired VNS therapy.

Despite these limitations, this series expands the published clinical experience with paired VNS therapy and helps address a gap in the literature regarding an underreported stroke population. These cases demonstrate the potential for paired VNS therapy to support meaningful UE recovery in patients with persistent deficits following posterior fossa stroke. Collectively, these observations suggest that patients with posterior circulation stroke may retain significant neuroplastic potential responsive to paired VNS therapy, even years after injury.

Acknowledgments

We thank Shannon Doherty, a Vivistim consultant, for proofreading the paper.

Disclosures

The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

Author Contributions

Conception and design: Conner, Burch, Nwankwo, Patil, Gandhi. Acquisition of data: Conner, Burch, Nwankwo, Zoana, Horowitz. Analysis and interpretation of data: Burch, Nelson, Zoana, Patil, Herrera Cano, Reddy. Drafting the article: Conner, Burch, Nwankwo, Nelson, Zoana, Patil, Horowitz, Herrera Cano, Reddy. Critically revising the article: Conner, Burch, Nelson, Zoana, Patil, Horowitz. Reviewed submitted version of manuscript: Conner, Burch, Nelson, Zoana, Patil, Herrera Cano. Approved the final version of the manuscript on behalf of all authors: Conner. Statistical analysis: Nelson. Administrative/technical/material support: Horowitz. Study supervision: Conner, Horowitz, Gandhi.

Correspondence

Christopher R. Conner: University of Connecticut Health, Farmington, CT. chconner@uchc.edu.

References

  • 1.Feigin VL, Brainin M, Norrving B.World stroke organization: global stroke fact sheet 2025. Int J Stroke. 2025;20(2):132-144. doi: 10.10.1177/17474930241308142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.He Q, Wang W, Zhang Y.Global, regional, and national burden of stroke, 1990-2021: a systematic analysis for global burden of disease 2021. Stroke. 2024;55(12):2815-2824. doi: 10.10.1161/STROKEAHA.124.048033 [DOI] [PubMed] [Google Scholar]
  • 3.Tang Q, Yang X, Sun M.Research trends and hotspots of post-stroke upper limb dysfunction: a bibliometric and visualization analysis. Front Neurol. 2024;15:1449729. doi: 10.10.3389/fneur.2024.1449729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schaechter JD.. Motor rehabilitation and brain plasticity after hemiparetic stroke. Prog Neurobiol. 2004;73(1):61-72. doi: 10.10.1016/j.pneurobio.2004.04.001 [DOI] [PubMed] [Google Scholar]
  • 5.Ng AC.. Posterior circulation ischaemic stroke. Am J Med Sci. 2022;363(5):388-398. doi: 10.10.1016/j.amjms.2021.10.027 [DOI] [PubMed] [Google Scholar]
  • 6.Go S.. Posterior circulation ischemic stroke. Mo Med. 2015;112(3):192-196. [PMC free article] [PubMed] [Google Scholar]
  • 7.Dawson J, Liu CY, Francisco GE.Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021;397(10284):1545-1553. doi: 10.10.1016/s0140-6736(21)00475-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nwankwo AK Patil SN Nelson MC Burch TG Bulsara KR Conner CR.. Implementation and results of paired vagus nerve stimulation (Vivistim) program for neurorestoration following ischemic stroke: a single-center experience. Surg Neurol Int. 2026;17(407):407. doi: 10.10.25259/SNI_1364_2025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Porter BA, Khodaparast N, Fayyaz T.Repeatedly pairing vagus nerve stimulation with a movement reorganizes primary motor cortex. Cereb Cortex. 2012;22(10):2365-2374. doi: 10.10.1093/cercor/bhr316 [DOI] [PubMed] [Google Scholar]
  • 10.Kimberley TJ, Cramer SC, Wolf SL.Long-term outcomes of vagus nerve stimulation paired with upper extremity rehabilitation after stroke. Stroke. 2025;56(8):2255-2265. doi: 10.10.1161/STROKEAHA.124.050479 [DOI] [PubMed] [Google Scholar]
  • 11.Hu Y Xiong R Pan S Huang K.. A narrative review of vagus nerve stimulation in stroke. J Cent Nerv Syst Dis. 2024;16:11795735241303069. doi: 10.10.1177/11795735241303069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wolf SL Catlin PA Ellis M Archer AL Morgan B Piacentino A.. Assessing Wolf Motor Function Test as outcome measure for research in patients after stroke. Stroke. 2001;32(7):1635-1639. doi: 10.10.1161/01.str.32.7.1635 [DOI] [PubMed] [Google Scholar]
  • 13.Lin KC Hsieh YW Wu CY Chen CL Jang Y Liu JS.. Minimal detectable change and clinically important difference of the Wolf Motor Function Test in stroke patients. Neurorehabil Neural Repair. 2009;23(5):429-434. doi: 10.10.1177/1545968308331144 [DOI] [PubMed] [Google Scholar]
  • 14.Woodbury M, Velozo CA, Thompson PA.Measurement structure of the Wolf Motor Function Test: implications for motor control theory. Neurorehabilit Neural Repair. 2010;24(9):791-801. doi: 10.10.1177/1545968310370749 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hijikata N, Kawakami M, Ishii R.Item difficulty of Fugl-Meyer Assessment for Upper Extremity in persons with chronic stroke with moderate-to-severe upper limb impairment. Front Neurol. 2020;11:577855. doi: 10.10.3389/fneur.2020.577855 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kernan WN, Viera AJ, Billinger SA.Primary care of adult patients after stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2021;52(9):e558-e571. doi: 10.10.1161/STR.0000000000000382 [DOI] [PubMed] [Google Scholar]
  • 17.Sun Z Baker W Hiraki T Greenberg JH.. The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat. Brain Stimul. 2012;5(1):1-10. doi: 10.10.1016/j.brs.2011.01.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Du L Yang Z Sheng H Liu M Sun Q.. Effects of long-term vagus nerve electrical stimulation therapy on acute cerebral infarction and neurological function recovery in post MCAO mice. Oxid Med Cell Longev. 2022;2022(1):8131391. doi: 10.10.1155/2022/8131391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ekici F Karson A Dillioglugil MO Gurol G Kir HM Ates N.. The effects of vagal nerve stimulation in focal cerebral ischemia and reperfusion model. Turk Neurosurg. 2013;23(4):451-457. doi: 10.10.5137/1019-5149.jtn.7114-12.1 [DOI] [PubMed] [Google Scholar]
  • 20.Xiang YX Wang WX Xue Z Zhu L Wang SB Sun ZH.. Electrical stimulation of the vagus nerve protects against cerebral ischemic injury through an anti-infammatory mechanism. Neural Regen Res. 2015;10(4):576-582. doi: 10.10.4103/1673-5374.155430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hays SA, Ruiz A, Bethea T.Vagus nerve stimulation during rehabilitative training enhances recovery of forelimb function after ischemic stroke in aged rats. Neurobiol Aging. 2016;43:111-118. doi: 10.10.1016/j.neurobiolaging.2016.03.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Khodaparast N, Kilgard MP, Casavant R.Vagus nerve stimulation during rehabilitative training improves forelimb recovery after chronic ischemic stroke in rats. Neurorehabilit Neural Repair. 2016;30(7):676-684. doi: 10.10.1177/1545968315616494 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Dawson J, Engineer ND, Cramer SC.Vagus nerve stimulation paired with rehabilitation for upper limb motor impairment and function after chronic ischemic stroke: subgroup analysis of the randomized, blinded, pivotal, VNS-REHAB device trial. Neurorehabil Neural Repair. 2023;37(6):367-373. doi: 10.10.1177/15459683221129274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kimberley TJ, Pierce D, Prudente CN.Vagus nerve stimulation paired with upper limb rehabilitation after chronic stroke. Stroke. 2018;49(11):2789-2792. doi: 10.10.1161/strokeaha.118.022279 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurosurgery: Case Lessons are provided here courtesy of American Association of Neurological Surgeons

RESOURCES